Advances in acute toxicity testing: strengths, weaknesses and regulatory acceptance

Abstract Safety assessment of chemicals, pharmaceuticals, food and food ingredients, cosmetics, industrial products is very crucial prior to their approval for human uses. Since the commencement of toxicity testing (about 500 years ago, since 1520), significant advances have been made with respect to the 3Rs (reduction, refinement and replacement) alternative approaches. This review is focused on the update in acute systemic toxicity testing of chemicals. Merits and demerits of these advances were also highlighted. Traditional LD50 test methods are being suspended while new methods are developed and endorsed by the regulatory body. Based on the refinement and reduction approaches, the regulatory body has approved fixed dose procedure (FDP), acute toxic class (ATC) method and up and down procedure (UDP) which involves few numbers of animals. In terms of replacement approach, the regulatory body approved 3T3 neutral red uptake (NRU), the normal human keratinocyte (NHK), and the 3T3 neutral red uptake (NRU) phototoxicity test for acute phototoxicity. However, other promising replacement alternatives such as organ on chip seeded with human cells for acute systemic toxicity and 3T3 neutral red uptake (NRU) cytotoxicity test for identifying substances not requiring classification, as well as the in silico approaches are yet to receive regulatory approval. With this backdrop, a collaborative effort is required from the academia, industries, regulatory agencies, government and scientific organizations to ensure speedily regulatory approval of the prospective alternatives highlighted.

[1]  R. Nema,et al.  Effective alternative methods of LD50 help to save number of experimental animals. , 2010 .

[2]  S. Parasuraman,et al.  Toxicological screening , 2011, Journal of pharmacology & pharmacotherapeutics.

[3]  M. Stephens,et al.  The first forty years of the alternatives approach: refining, reducing, and replacing the use of laboratory animals , 2001 .

[4]  P. Botham,et al.  Acute systemic toxicity--prospects for tiered testing strategies. , 2004, Toxicology in vitro : an international journal published in association with BIBRA.

[5]  Mark T D Cronin,et al.  The Current Status and Future Applicability of Quantitative Structure–activity Relationships (QSARs) in Predicting Toxicity , 2002, Alternatives to laboratory animals : ATLA.

[6]  A. Hayes,et al.  Loomis's Essentials of Toxicology , 1996 .

[7]  Sonali K Doke,et al.  Alternatives to animal testing: A review , 2013, Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society.

[8]  Thomas Hartung,et al.  From in vivo to in vitro: The medical device testing paradigm shift. , 2017, ALTEX.

[9]  Helmut Segner,et al.  MEIC Evaluation of acute systemic toxicity. Part VII. Prediction of human toxicity by results from testing of the first 30 reference chemicals with 27 further In Vitro assays , 2000 .

[10]  Menghang Xia,et al.  Alternative approaches for identifying acute systemic toxicity: Moving from research to regulatory testing. , 2017, Toxicology in vitro : an international journal published in association with BIBRA.

[11]  P. Erkekoğlu,et al.  3 R Principle and Alternative Toxicity Testing Methods , 2013 .

[12]  Halder Maria Elisabeth,et al.  European Union Reference Laboratory for Alternatives to Animal Testing , 2018 .

[13]  Luis G Valerio,et al.  In silico toxicology for the pharmaceutical sciences. , 2009, Toxicology and applied pharmacology.

[14]  Gertrude-Emilia Costin.  REVIEW ARTICLE Advances in science: next generation of lab tools, models and testing platforms used in predictive toxicology , 2017 .

[15]  Chris Harbron,et al.  In search of preclinical robustness , 2012, Nature Reviews Drug Discovery.

[16]  Uwe Marx,et al.  Biology-inspired microphysiological system approaches to solve the prediction dilemma of substance testing. , 2016, ALTEX.

[17]  Vicky Robinson,et al.  Finding alternatives: an overview of the 3Rs and the use of animals in research , 2005 .

[18]  N. Shanks,et al.  Are animal models predictive for humans? , 2009, Philosophy, ethics, and humanities in medicine : PEHM.

[19]  Stuart Creton,et al.  Pharmaceutical toxicology: designing studies to reduce animal use, while maximizing human translation. , 2013, Regulatory toxicology and pharmacology : RTP.

[20]  B. Davletov,et al.  A Cell Line for Detection of Botulinum Neurotoxin Type B , 2017, Front. Pharmacol..

[21]  A. Saganuwan.  A modified arithmetical method of Reed and Muench for determination of a relatively ideal median lethal dose (LD50) , 2011 .

[22]  B Ekwall,et al.  Overview of the Final MEIC Results: II. The In Vitro--In Vivo Evaluation, Including the Selection of a Practical Battery of Cell Tests for Prediction of Acute Lethal Blood Concentrations in Humans. , 1999, Toxicology in vitro : an international journal published in association with BIBRA.

[23]  D. Lorke.  A new approach to practical acute toxicity testing , 1983, Archives of Toxicology.

[24]  M. Sjöström,et al.  MEIC evaluation of acute systemic toxicity : Part VIII. Multivariate partial least squares evaluation, including the selection of a battery of cell line tests with a good prediction of human acute lethal peak blood concentrations for 50 chemicals , 2000 .

[25]  Andrew Worth,et al.  Metabolism: A Bottleneck in In Vitro Toxicological Test Development , 2006, Alternatives to laboratory animals : ATLA.

[26]  Thomas Hartung,et al.  Food for Thought ... on mapping the human toxome. , 2011, ALTEX.

[27]  M. A. Randhawa.  Calculation of LD50 values from the method of Miller and Tainter, 1944. , 2009, Journal of Ayub Medical College, Abbottabad : JAMC.

[28]  W. Russell,et al.  Ethical and Scientific Considerations Regarding Animal Testing and Research , 2011, PloS one.

[29]  Vladimir B Bajic,et al.  In silico toxicology: computational methods for the prediction of chemical toxicity , 2016, Wiley interdisciplinary reviews. Computational molecular science.

[30]  Feng Luan,et al.  In silico assessment of the acute toxicity of chemicals: recent advances and new model for multitasking prediction of toxic effect. , 2015, Mini reviews in medicinal chemistry.

[31]  D. Arome,et al.  A New Method for Determining Acute Toxicity in Animal Models , 2013, Toxicology international.

[32]  S. Saganuwan.  Toxicity studies of drugs and chemicals in animals: an overview , 2017 .

[33]  Thomas Hartung,et al.  Are in vitro tests suitable for regulatory use? , 2009, Toxicological sciences : an official journal of the Society of Toxicology.

[34]  Eren Ozcagli,et al.  Using Stem Cells in Toxicological Assessments , 2016 .

[35]  C. le Grimellec,et al.  Primary culture of rabbit proximal tubules as a cellular model to study nephrotoxicity of xenobiotics. , 1993, Kidney international.

[36]  D. Blacker.  Food for thought. , 2013, JAMA neurology.

[37]  Robert D. Combes,et al.  The Current Status of Food Additives Toxicity Testing and the Potential for Application of the Three Rs , 2001, Alternatives to laboratory animals : ATLA.

[38]  W. White,et al.  Reflections on Improved Health Status of Rodents Bred for Research: Contributions to the Reduction and Refinement of Animal Use , 2009, Alternatives to laboratory animals : ATLA.

[39]  S E Escher,et al.  Evaluation of inhalation TTC values with the database RepDose. , 2010, Regulatory toxicology and pharmacology : RTP.

[40]  Ruth A. Roberts,et al.  Development and use of in vitro alternatives to animal testing by the pharmaceutical industry 1980–2013 , 2015 .

[41]  Thomas Hartung,et al.  Correlating in vitro data to in vivo findings for risk assessment. , 2014, ALTEX.